Clinical Trials Crypto News
Clinical Trials crypto news from TLT: 2 original briefs, each synthesised from across 50+ outlets, cross-checked for agreement on the key figures, enriched with live market data and Bitcoin-timestamped for provenance. The latest Clinical Trials developments are below — updated hourly, with the data context no single outlet carries.
OpenAI Expands AI Drug Development with Orchestra Acquisition
OpenAI acquires Orchestra Bio to integrate AI agents for managing clinical trial delays into its Rosalind platform.
ImmunityBio's ANKTIVA Shows Promise in Bladder Cancer Despite Stock Decline
ImmunityBio's ANKTIVA demonstrates a 71% complete response rate in bladder cancer trials, but the company's stock falls 7.25%.